000 | 00944 a2200313 4500 | ||
---|---|---|---|
005 | 20250510211208.0 | ||
264 | 0 | _c19790523 | |
008 | 197905s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(79)90843-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHolt, D W | |
245 | 0 | 0 |
_aComplications of disopyramide. _h[electronic resource] |
260 |
_bLancet (London, England) _cMar 1979 |
||
300 |
_a491-2 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aDigoxin _xblood |
650 | 0 | 4 |
_aDisopyramide _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPyridines _xadverse effects |
700 | 1 | _aHayler, A M | |
773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8114 _gp. 491-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(79)90843-2 _zAvailable from publisher's website |
999 |
_c83105 _d83105 |